News

Case study looks at a 90-year-old patient with a sebaceous gland carcinoma with corneal and bulbar conjunctival involvement, but the eyelid was spared.

Cathleen McCabe, MD, presents results of a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.

Case study of 2 sisters with Leber’s congenital amaurosis (LCA) analyzes ocular findings, connection.

Jag Dosanjh, senior vice president of U.S. Eye Care, Allergan, an AbbVie company, offers a preview of the company's latest innovations, developments, and what attendees can look forward to at ASCRS 2021.

This announcement was made at the 2021 ASCRS annual meeting.

A new report has found that glaucoma specialists’ procedure of choice has changed as a result of the COVID-19 pandemic.

Dual imaging may reduce costs, unnecessary referrals, telehealth study results show.

This research was a finalist in the 2020 Ophthalmology Times® Research Scholar Honoree Program.

Physician offers practical advice for the use of systems.

AAO, Surgical Care Coalition teaming up to ensure the final version of the rule is fair to ophthalmologists and surgeons as one company is expressing its disappointment in the proposal.

Nanoscope Therapeutics Inc. has dosed its first patient in a late-stage Phase 2b trial of a gene therapy that delivers multi-characteristic opsin to retinal cells.

Although minimally invasive procedure gives hope, additional research is required.

Administration has minimal impact on patients’ perception of pain.

The Gilbert Family Foundation is collaborating with the Children’s Oncology Group and Children’s Hospital of Philadelphia to validate a tool to measure progressive vision loss.

Australian researchers reported investigating the potential use of CRISPR, the gene-editing technology, to stop SARS-CoV-2 virus transmission in infected human cells.

According to iSTAR Medical, the STAR-V study will investigate the device in 350 patients with primary open angle glaucoma.

Looking for potential substitutes to a frequently overused response.

Alkeus Pharmaceuticals, Inc, announced Thursday that the FDA has granted Breakthrough Therapy Designation (BTS) for ALK-001 (C20-D3-vitamin A) for the treatment of Stargardt disease.

Study highlights extracellular matrix-related proteins expressed in PVR.

A team of investigators has found that the retina could offer signs of possible COVID-19 infection before they appear in other parts of the body.

New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.

Holographic technology offers after-surgery glimpse for surgeons, patients.

Measures of inflammation can predict treatment outcomes for patients.

The primary barriers to COVID-19 vaccine development are manufacturing constraints.

Usher syndrome 1G protein SANS regulates the splicing of genes, particularly those linked to Usher syndrome, which can lead to early vision loss form RP.

There’s no shortage of diet programs—Paleo, Mediterranean, intermittent fasting—all claiming to be the best option for a healthy life. Research has shown that poor lifestyle choices, including unhealthy diets, contribute to many diseases and that simply adhering to good nutrition can even prevent some health issues.

Pressure-dependent optic nerve disease, retinal disease.